ID24198A - Penanganan diabetes dengan tiazolidindion dan sulfonilurea - Google Patents

Penanganan diabetes dengan tiazolidindion dan sulfonilurea

Info

Publication number
ID24198A
ID24198A IDW20000074A ID20000074A ID24198A ID 24198 A ID24198 A ID 24198A ID W20000074 A IDW20000074 A ID W20000074A ID 20000074 A ID20000074 A ID 20000074A ID 24198 A ID24198 A ID 24198A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
sulfonilurea
diabetes management
diabetes
management
Prior art date
Application number
IDW20000074A
Other languages
English (en)
Indonesian (id)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID24198A publication Critical patent/ID24198A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20000074A 1997-07-18 1998-07-16 Penanganan diabetes dengan tiazolidindion dan sulfonilurea ID24198A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ID24198A true ID24198A (id) 2000-07-13

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000074A ID24198A (id) 1997-07-18 1998-07-16 Penanganan diabetes dengan tiazolidindion dan sulfonilurea

Country Status (41)

Country Link
EP (1) EP0998291B2 (fr)
JP (2) JP2001510158A (fr)
KR (1) KR100680667B1 (fr)
CN (1) CN1264302A (fr)
AP (1) AP1318A (fr)
AR (2) AR016768A1 (fr)
AT (1) ATE366577T1 (fr)
AU (1) AU743269B2 (fr)
BG (1) BG64892B1 (fr)
BR (1) BR9810904A (fr)
CA (1) CA2297115C (fr)
CO (1) CO4940422A1 (fr)
CY (1) CY1107745T1 (fr)
CZ (1) CZ302668B6 (fr)
DE (1) DE69838066T3 (fr)
DK (1) DK0998291T4 (fr)
DZ (1) DZ2564A1 (fr)
EA (1) EA003303B1 (fr)
ES (1) ES2290989T5 (fr)
GB (1) GB9715306D0 (fr)
HK (1) HK1029272A1 (fr)
HU (1) HU229119B1 (fr)
ID (1) ID24198A (fr)
IL (1) IL134045A0 (fr)
IN (1) IN189035B (fr)
MA (1) MA26522A1 (fr)
MY (1) MY138246A (fr)
NO (1) NO326356B1 (fr)
NZ (3) NZ520652A (fr)
OA (1) OA11632A (fr)
PE (1) PE99799A1 (fr)
PL (2) PL338127A1 (fr)
PT (1) PT998291E (fr)
SI (1) SI0998291T2 (fr)
SK (2) SK287823B6 (fr)
TR (1) TR200000135T2 (fr)
TW (1) TW586926B (fr)
UA (1) UA70302C2 (fr)
UY (1) UY25103A1 (fr)
WO (1) WO1999003476A1 (fr)
ZA (1) ZA986365B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897547A1 (fr) * 1999-07-13 2008-03-12 Medicure Inc. Utilisation de dérivés de phosphate de pyridoxal dans le traitement du diabète et de ses complications correspondantes
EP1832291A3 (fr) * 1999-07-13 2009-11-04 Medicure Inc. utilisation de pyridoxal phosphate pour le traitement du diabete
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
WO2002055009A1 (fr) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Systeme de liberation espacee de medicaments
ZA200602056B (en) 2003-10-31 2007-05-30 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
AR058605A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Preparacion solida

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (fr) * 1988-03-08 1989-09-21 Pfizer Inc. Derives de thiaxolidinedione hypoglycemiques
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Agents d'oxazolidinedione hypoglycemiques
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
CY1107745T1 (el) 2013-04-18
EP0998291B1 (fr) 2007-07-11
WO1999003476A1 (fr) 1999-01-28
KR20010021948A (ko) 2001-03-15
PT998291E (pt) 2007-10-11
EP0998291A1 (fr) 2000-05-10
SI0998291T1 (sl) 2007-12-31
PL338127A1 (en) 2000-09-25
SK288053B6 (sk) 2013-03-01
NO20000229D0 (no) 2000-01-17
CZ302668B6 (cs) 2011-08-24
PE99799A1 (es) 1999-12-22
IL134045A0 (en) 2001-04-30
CA2297115A1 (fr) 1999-01-28
NZ501256A (en) 2002-09-27
SK287823B6 (sk) 2011-11-04
DE69838066T3 (de) 2012-03-29
AP2000001734A0 (en) 2000-03-31
NO326356B1 (no) 2008-11-17
TR200000135T2 (tr) 2000-05-22
IN189035B (fr) 2002-12-07
BG64892B1 (bg) 2006-08-31
MY138246A (en) 2009-05-29
OA11632A (en) 2004-11-22
MA26522A1 (fr) 2004-12-20
BG104139A (en) 2000-11-30
HUP0003634A3 (en) 2003-04-28
ES2290989T5 (es) 2011-11-11
DK0998291T3 (da) 2007-11-05
UA70302C2 (uk) 2004-10-15
DZ2564A1 (fr) 2003-02-15
JP2005247865A (ja) 2005-09-15
GB9715306D0 (en) 1997-09-24
HUP0003634A2 (hu) 2001-07-30
NZ515555A (en) 2002-09-27
NO20000229L (no) 2000-01-17
ES2290989T3 (es) 2008-02-16
KR100680667B1 (ko) 2007-02-09
HU229119B1 (en) 2013-08-28
AU743269B2 (en) 2002-01-24
CA2297115C (fr) 2010-02-23
PL199125B1 (pl) 2008-08-29
ZA986365B (en) 2000-01-17
EA200000141A1 (ru) 2000-08-28
HK1029272A1 (en) 2001-03-30
AR019331A2 (es) 2002-02-13
CO4940422A1 (es) 2000-07-24
AU8448798A (en) 1999-02-10
BR9810904A (pt) 2000-09-26
SK602000A3 (en) 2000-07-11
AP1318A (en) 2004-10-22
EP0998291B2 (fr) 2011-07-06
NZ520652A (en) 2004-06-25
DK0998291T4 (da) 2011-09-26
CZ2000173A3 (en) 2001-05-16
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
AR016768A1 (es) 2001-08-01
CN1264302A (zh) 2000-08-23
DE69838066D1 (de) 2007-08-23
TW586926B (en) 2004-05-11
JP2001510158A (ja) 2001-07-31
ATE366577T1 (de) 2007-08-15
UY25103A1 (es) 2000-12-29
SI0998291T2 (sl) 2011-10-28

Similar Documents

Publication Publication Date Title
ID21361A (id) Baterai dan metode pembuatannya
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
ID19422A (id) Piridina dan bifenil tersubstitusi
FI972292A (fi) Diabeteksen hallinta
ID22957A (id) Senyawa dan penggunaannya
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID24476A (id) Arilsulfonamida dan analognya
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
EE03427B1 (et) Pihusti sõlm ja selle kasutamine
PT996701E (pt) Polialquilenoiminas alcoxiladas compativeis com lixivia
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID23372A (id) Pengobatan diabetes dengan tiazolidindion dan metformin
ID24428A (id) Engontrol suhu dan kelembaban lewat peningkatan yang disertai pemanasan-ulang
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
DE69825982D1 (de) Spritze
ID22708A (id) Perangkai gen dan metodanya
ID20354A (id) Penyaput film dan komposisi penyaput film berdasarkan atas dekstrin
DE69817432D1 (de) Cycloolefinpolymere und deren Verwendung
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID24872A (id) Komposisi pengawet berdasarkan senyawa donor formaldehide dan iodopropinil
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina